Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Misses Revenue Estimates
- Fulgent Genetics reported a quarterly loss of $0.01 per share, beating estimates by 96.97%. - Revenues were $64.49 million, missing estimates by 1.90%. - The stock has underperformed the market, with a Zacks Rank of #3 (Hold). Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
View signal analysis